Commonwealth Equity Services’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
QCM
Commonwealth Equity Services's TXG Position: Q3 2025 in Review
Commonwealth Equity Services sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 13,673 shares — an estimated $158K sold.
Commonwealth Equity Services first reported a position in TXG in Q3 2020 and held it in 17 quarters. The position peaked at $2.15M in Q2 2021. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.
- Commonwealth Equity Services reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
- Commonwealth Equity Services sold 13,673 10x Genomics shares in Q3 2025, an estimated $158K.
- Commonwealth Equity Services first reported a position in 10x Genomics in Q3 2020 and held it in 17 quarters.
- Commonwealth Equity Services's 10x Genomics position peaked at $2.15M in Q2 2021.
- 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.
Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.